Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Diabetes Care|June 6, 1998
Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes GroupR G Thompson, L Pearson, S L Schoenfeld, et al.Diabetes|February 1, 1989
Systematic variation and differences in insulin-autoantibody measurementsT J Wilkin, S L Schoenfeld, J L Diaz, et al.Journal of Immunological Methods|September 18, 1992
Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetesM J Hegewald, S L Schoenfeld, D K McCulloch, et al.Diabetes|May 1, 1990
Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family StudyD K McCulloch, L J Klaff, S E Kahn, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|April 23, 2003
Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needleH G Dörr, S Zabransky, E Keller, et al.The American Journal of Medicine|January 16, 1998
Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatmentP D Miller, N B Watts, A A Licata, et al.Pageof 1